Sonoma Pharmaceuticals Inc (SNOA) — Cash Flow Quality Index
Sonoma Pharmaceuticals Inc (SNOA) has a Cash Flow Quality Index of -2.30x as of June 2020. Operating cash flow of $-2.28 Million is below net income of $993.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Sonoma Pharmaceuticals Inc cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sonoma Pharmaceuticals Inc Cash Flow Quality Index (2014–2017)
Historical Cash Flow Quality Index for Sonoma Pharmaceuticals Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check SNOA capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Sonoma Pharmaceuticals Inc (2014–2017)
Year-by-year earnings quality comparison for Sonoma Pharmaceuticals Inc. For live market cap and the full company financial profile, see SNOA market cap.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2017 | -0.88x | $-8.17 Million | $9.27 Million | ▲ +32.7% |
| 2014 | -1.31x | $-4.89 Million | $3.73 Million | — |